ZEISS Launches MyoConsult: A State-Of-The-Art Myopia Management Software

Aalen, Germany | 16 January 2026 | ZEISS Vision Care

• Easy data capture, management & seamless workflow integration
• Evidence-based conversations on individual progression
• Fast and clear decisions
• A personalized easy-to-understand report

With the global rise of progressive myopia, eye care professionals are increasingly expected to offer personalized management services and comprehensive consultations. Now, ZEISS announces the launch of ZEISS MyoConsult, its first myopia consultation software to empower eye care professionals to deliver personalized myopia care and support lifelong visual health, especially for children.

ZEISS MyoConsult enhances myopia management by providing efficient long-term myopia monitoring with unified patient records and streamlined workflows through automatic data transfer from ZEISS devices reducing manual data entry. The software records critical measurements including refraction, axial length and keratometry along with factors influencing myopia progression (such as age, gender, ethnicity, family history, near work, outdoor time, and previous interventions) and saves it in unique profiles for effective monitoring. ZEISS MyoConsult generates visit-by-visit summaries and maintains unified records, allowing eye care professionals to focus on patient care. Connected through ZEISS VISUCONSULT 500, ZEISS MyoConsult supports workflow efficiency, creating a data-driven practice environment for informed, evidence-based management of myopia in children. 9 out of 10 eye care professionals confirm ZEISS MyoConsult is like a trusted navigation system, enhancing their clinical judgment without replacing it.¹ While it realizes its full potential when connected to the ZEISS ecosystem, ZEISS MyoConsult can also be used as a stand-alone solution.

ZEISS MyoConsult offers clear graphs and validated models to support confident conversations about myopia management. By comparing initial projections with current measurements and benchmarking against peers, the software enhances transparency, builds trust, and helps eye care professionals explain how the child’s myopia is developing and how effective management is. This makes it easier for professionals to engage families in ongoing care and encourage adherence to treatment plans. 9 out of 10 eye care professionals agree that ZEISS MyoConsult turns complex data into a clear story - easy to follow, and even easier to explain.¹

ZEISS MyoConsult utilizes intuitive visuals to highlight progression risk, treatment impact, and predicted outcomes, enabling eye care professionals to assess treatment effectiveness quickly and confidently. By capturing and consolidating relevant data, the software automatically compares visit-to-visit measurements. This data-driven guidance supports evidence-based conversations, while all final treatment decisions remain fully in the eye care professional’s hands.

ZEISS MyoConsult empowers parents with a consumer report that summarizes their situation, keeping them informed and confident. By automatically generating a two-page report after each visit, the software translates clinical data into intuitive visuals and straightforward explanations for consumers, summarizing treatment efficacy, lifestyle guidance, and recommended actions. This approach helps parents and children to stay engaged between visits and build trust. 9 out of 10 eye care professionals confirm that parents leave a ZEISS MyoConsult visit with clear understanding and confidence in the care plan and that with ZEISS MyoConsult’s progression visuals, parents commit faster.¹

ZEISS MyoConsult will be launched gradually in various countries starting in spring 2026. Together with the ZEISS MYO 200 biometer it will form part of the ZEISS myopia management portfolio and contribute towards ZEISS’ aim to provide consumers with great vision and a lifetime of best possible visual health.